We are live on ! Find out more
RGNX icon

Regenxbio
RGNX

85 hedge funds and large institutions have $401M invested in Regenxbio in 2017 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 33 increasing their positions, 21 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 9

57% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 21

18% more capital invested

Capital invested by funds: $339M → $401M (+$61.9M)

9% more funds holding

Funds holding: 78 → 85 (+7)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.5% less ownership

Funds ownership: 69.11% → 68.61% (-0.5%)

Holders
85
Holders Change
+7
Holders Change %
+8.97%
% of All Funds
2.12%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
21
Increased
33
Reduced
21
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$45.8M
2
RG
Redmile Group
California
+$24.5M
3
RI
RTW Investments
New York
+$18.8M
4
Citadel Advisors
Citadel Advisors
Florida
+$9.31M
5
PHS
PFM Health Sciences
California
+$5.78M

Top Sellers

Rank Fund Capital Flow
1
BCPEM
Bain Capital Public Equity Management
Massachusetts
-$11.6M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$6.58M
3
VC
Vivo Capital
California
-$6.53M
4
Jennison Associates
Jennison Associates
New York
-$5.42M
5
NCM
Numina Capital Management
New York
-$3.44M
Name Holding Trade Value Shares
Change 		Change in
Stake
UOC
26
UBS O'Connor
Illinois
$2.58M +$2.57M +133,410 New
CAM
27
Cormorant Asset Management
Massachusetts
$2.32M -$709K -36,741 -23%
Deutsche Bank
28
Deutsche Bank
Germany
$2.13M +$912K +47,278 +75%
MIM
29
Monashee Investment Management
Massachusetts
$1.74M – – –
SSA
30
Schonfeld Strategic Advisors
New York
$1.49M +$712K +36,911 +92%
Mirae Asset Global Investments
31
Mirae Asset Global Investments
South Korea
$1.46M +$999K +51,802 +218%
Charles Schwab
32
Charles Schwab
California
$1.42M +$82.4K +4,275 +6%
CHP
33
Castle Hook Partners
New York
$1.16M +$1.16M +60,000 New
TCIM
34
TIAA CREF Investment Management
New York
$1.07M -$79.6K -4,125 -7%
Ameriprise
35
Ameriprise
Minnesota
$1.01M -$70.3K -3,645 -7%
Bank of America
36
Bank of America
North Carolina
$992K +$11.5K +597 +1%
GC
37
GMT Capital
Georgia
$992K +$991K +51,400 New
Tudor Investment Corp
38
Tudor Investment Corp
Connecticut
$979K +$978K +50,730 New
HCM
39
Highbridge Capital Management
New York
$965K +$964K +50,000 New
GAMA
40
Graticule Asia Macro Advisors
New York
$949K – – –
Victory Capital Management
41
Victory Capital Management
Texas
$907K +$214K +11,079 +31%
NFA
42
Nationwide Fund Advisors
Ohio
$887K +$63.3K +3,280 +8%
Swiss National Bank
43
Swiss National Bank
Switzerland
$822K +$193K +10,000 +31%
Morgan Stanley
44
Morgan Stanley
New York
$821K -$587K -30,414 -42%
PPA
45
Parametric Portfolio Associates
Washington
$790K +$496K +25,729 +169%
California State Teachers Retirement System (CalSTRS)
46
California State Teachers Retirement System (CalSTRS)
California
$770K -$36.6K -1,900 -5%
AI
47
ArchPoint Investors
Florida
$714K +$714K +37,000 New
TA
48
Teachers Advisors
New York
$682K +$28.3K +1,467 +4%
Goldman Sachs
49
Goldman Sachs
New York
$681K +$163K +8,429 +31%
SO
50
STRS Ohio
Ohio
$634K +$307K +15,900 +94%
1
2
3 4

RGNX Hedge Fund Activity: Q1 2017 in Review

85 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Regenxbio (RGNX) for Q1 2017, worth a combined $401M — up 18% from $339M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new RGNX positions and 9 closed out — a net gain of 12 holders — while 33 added to existing stakes and 21 trimmed.

The largest buyer was BlackRock, adding an estimated $45.8M. The largest seller was Bain Capital Public Equity Management, cutting an estimated $11.6M.

  • 85 institutional investors held Regenxbio (RGNX) as of Q1 2017, up from 78 in Q4 2016.
  • Funds reported $401M of Regenxbio stock for Q1 2017, up 18% quarter-over-quarter.
  • 21 funds opened new Regenxbio positions in Q1 2017 and 9 closed out, a net change of +12 holders.
  • The largest Regenxbio buyer in Q1 2017 was BlackRock, an estimated $45.8M added.
  • The largest Regenxbio seller in Q1 2017 was Bain Capital Public Equity Management, an estimated $11.6M sold.

Based on aggregated 13F filings for Q1 2017.